Tag Archives: approved

Soaring stocks and the reasons why (INHX, SMSI, RL)

Posted on January 9, 2012 by Josie Middleton

In this report: Inhibitex (NASDAQ:INHX), Smith Micro Software (NASDAQ:SMSI) and Polo Ralph Lauren (NYSE:RL).

Inhibitex (NASDAQ:INHX) shares soared by more than 140 percent today after the company became a $2.5 billion acquisition target for Bristol Myers Squibb (NYSE:BMY). The …

Posted in Latest Headlines, Reports | Tagged acquistion, approved, Bristol-Myers Squibb, Buy, CEO, company, conviction buy list, Goldman Sachs, growth, GS, hepatitis C, Inhibitex, INHX, investment, NASDAQ, NASDAQ:INHX, NASDAQ:SMSI, NYSE, NYSE:BMY, NYSE:GS, NYSE:RL, Polo Ralph Lauren, rating, report, RL, Smith Micro Software, SMSI, Sprint, Target, treatments, upgrade | Comments Off

Big time losers and the reasons why (FRO, THQI, S)

Posted on December 7, 2011 by Josie Middleton

In this report: Frontline (NYSE:FRO), THQ Inc. (NASDAQ:THQI) and Sprint Nextel (NYSE:S).

Frontline (NYSE:FRO) shares have dropped by more than 13 percent today after dropping 21 percent yesterday after the company announced that it board had approved a restructuring of …

Posted in Latest Headlines, Reports | Tagged Analysts, approved, assets, board, company, cowen, debt, Doug Creutz, downgrade, expectations, firm, fiscal, FRO, Frontline, NASDAQ, NASDAQ:THQI, NYSE, NYSE:FRO, NYSE:S, profit, rating, RBC Capital, report, restructuring, S, share, Sprint Nextel, THQ Inc., THQI, trades | Comments Off

What the fuss Navistar, Tiffany’s and Abbot Labs?

Posted on November 30, 2011 by Josie Middleton

In this report: Navistar International (NYSE:NAV), Tiffany’s (NYSE:TIF) and Abbott Laboratories (NYSE:ABT).

Navistar International (NYSE:NAV) shares rose by more than 6.4 percent on Wednesday after the company received an upgrade by an analysts at Goldman Sachs. The firm upgraded the …

Posted in Latest Headlines, Reports | Tagged Abbott Laboratories, ABT, analyst, approved, blood test, company, earnings, expected, firm, Food and Drug Administration, forecasted, Goldman Sachs, investment bank, Jerry Revich, luxury items, NAV, Navistar international, net income, NYSE, NYSE:ABT, NYSE:NAV, NYSE:TIF, outlook, patients, report, sell, share, shares, shoppers, TIF, Tiffany’s, upgrade, vitamin D | Comments Off

What the fuss Amarin, Netflix and Aegon?

Posted on November 25, 2011 by Martin Timble

In this report: Amarin Corp. (NASDAQ:AMRN), Netflix (NASDAQ:NFLX) and Aegon (NYSE:AEG).

Amarin Corp. (NASDAQ:AMRN) gained over 6 percent on Friday after the company announced that the Food and Drug Administration has approved its AMR101 marketing application and that it has …

Posted in Latest Headlines, Reports | Tagged 2012, AEG, Aegon, Amarin Corp., AMRN, analyst, approved, Buy, CEO, company, customers, debt, downgraded, filing, firm, Food and Drug Administration, Goldman Sachs, insurer, investors, issuing, marketing application, NASDAQ, NASDAQ:AMRN, NASDAQ:NFLX, Netflix, NFLX, NYSE, NYSE:AEG, raise, rating, report, split, stock, streaming | Comments Off

What’s up McCormich & Schmick, DealerTrack and Rackspace Hosting?

Posted on November 8, 2011 by Martin Timble

In this Article: McCormick & Schmick’s Seafood Restaurants (NASDAQ:MSSR), DealerTrack Holdings (NASDAQ:TRAK) and Rackspace Hosting (NYSE:RAX).

McCormick & Schmick’s Seafood Restaurants (NASDAQ:MSSR) is trading over 27 percent higher today after the company announced that they have agreed to be acquired …

Posted in Latest Headlines, Reports | Tagged acquired, agreed, analyst, approved, cash, cloud computing, deal, DealerTrack Holdings, earnings, expectations, landry, McCormick & Schmick’s Seafood Restaurants, MSSR, NASDAQ, NASDAQ:MSSR, NASDAQ:TRAK, NYSE, NYSE:RAX, outstanding shares, quarter, Rackspace Hosting, RAX, revenue, tender offer, trading, TRAK, valued, Wall Street | Comments Off

At the bell buzz (THOR, MTZ, CHE)

Posted on November 7, 2011 by pmarek

In this report: Thoratec Corp. (NASDAQ:THOR), MasTec (NYSE:MTZ) and Chemed Corp. (NYSE:CHE).

Thoratec Corp. (NASDAQ:THOR) has dropped by more than 1.5 percent today to $28.93 per share. The company announced today that it has approved a buyback program for $50 …

Posted in Latest Headlines, Reports | Tagged approved, authorized, buyback, CHE, Chemed Corp., company, dividend, earnings, estimates, MasTec, MTZ, NASDAQ:THOR, NYSE:CHE, NYSE:MTZ, outlook, profit, repurchase, revenue, share, shareholder, stock, THOR, Thoratec Corp., trading, Wall Street | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Tag Archives: approved

Soaring stocks and the reasons why (INHX, SMSI, RL)

What the fuss Amarin, Netflix and Aegon?

Follow us

Most Popular Posts

blogs